Ocular surface disease (OSD) is a broad term for conditions that damage the outermost layers of the eye, specifically the cornea and the conjunctiva (the clear membrane covering the white of your eye). Dry eye disease is the most common form, but OSD also includes allergic eye conditions, infections, and inflammatory disorders that disrupt the delicate system keeping your eyes moist and protected. It affects millions of people and ranges from mild irritation to sight-threatening damage.
How the Tear Film Works
Understanding OSD starts with the tear film, a thin but complex coating that protects and nourishes the front of your eye every time you blink. It has three layers, each with a distinct job. The innermost mucin layer acts like an anchor, helping tears stick evenly to the surface of the cornea, which is naturally water-repellent. Without it, tears would bead up and slide off rather than forming a smooth, stable coating.
The middle aqueous layer is the thickest. It supplies oxygen, glucose, and electrolytes to the cornea (which has no blood vessels of its own), flushes away debris and toxins, and keeps the surface lubricated. The outermost lipid layer is an ultra-thin oil barrier that sits at the air-tear interface. Its primary role is slowing evaporation so the aqueous layer doesn’t dry out between blinks.
When any of these three layers is deficient or unstable, the tear film breaks down faster than it should. In a healthy eye, the tear film remains intact for at least 10 seconds after a blink. A breakup time under 10 seconds is considered abnormal and is one of the hallmarks of evaporative dry eye. As the surface dries, salt concentration in the remaining tears rises. This hyperosmolarity triggers inflammatory signals that damage corneal cells and the goblet cells responsible for producing mucin, creating a self-reinforcing cycle: inflammation causes more dryness, which causes more inflammation.
Common Symptoms
OSD often starts with symptoms that seem minor and easy to dismiss. The most frequently reported include a burning or stinging sensation, a gritty feeling as if something is stuck in the eye (foreign body sensation), itching, and excessive tearing. That last one surprises many people. When the eye surface is chronically dry or irritated, reflex tearing kicks in, flooding the eye with watery tears that lack the right balance of mucin and oil to actually help.
As the condition progresses, you may notice sensitivity to light, redness, and episodes of blurred vision that temporarily clear when you blink. These symptoms tend to worsen in dry or windy environments, during prolonged screen use, or in air-conditioned rooms. Many people describe their eyes feeling worst at the end of the day.
What Causes It
OSD has a long list of triggers, but most cases fall into two overlapping categories: your eyes aren’t producing enough tears, or the tears you produce are evaporating too quickly.
Reduced tear production often has a systemic cause. Autoimmune conditions are among the strongest risk factors. Sjögren’s syndrome directly attacks the glands that produce tears and saliva. Rheumatoid arthritis, diabetes, and thyroid disorders like Graves’ disease also increase risk. Aging plays a role as well, since tear production naturally declines over time, and hormonal shifts during menopause make women particularly susceptible.
Excessive evaporation is usually linked to meibomian gland dysfunction (MGD), where the tiny oil glands along your eyelid margins become blocked or produce poor-quality oil. Without that lipid layer, tears evaporate far too quickly. Environmental factors compound the problem. Low humidity, wind exposure, prolonged screen time (which reduces your blink rate by as much as half), and certain medications like antihistamines, antidepressants, and blood pressure drugs all contribute. Long-term use of preserved eye drops, including some glaucoma medications, can also damage the ocular surface through a preservative called benzalkonium chloride, which causes redness, stinging, and direct corneal cell injury.
How It’s Diagnosed
Diagnosis typically involves both a symptom questionnaire and a series of in-office tests. Two validated screening tools, the DEQ-5 and OSDI, help quantify how much your symptoms affect daily life. If scores suggest dry eye, your eye doctor will move to objective testing.
Tear breakup time is measured by placing a small amount of fluorescein dye on the eye and watching through a slit lamp to see how quickly the tear film destabilizes after a blink. Anything under 10 seconds points to an unstable tear film. Tear osmolarity testing measures salt concentration, with elevated readings confirming excessive evaporation or low production. Staining with fluorescein and lissamine green dyes highlights areas of damage on the cornea, conjunctiva, and eyelid margin that aren’t visible to the naked eye.
The Schirmer test measures raw tear volume by tucking a small strip of filter paper under the lower eyelid for five minutes. Wetting of more than 15 millimeters is normal. Between 10 and 15 millimeters suggests possible dryness. Between 5 and 10 millimeters indicates moderate dry eye, and less than 5 millimeters signals severe tear deficiency.
Treatment by Severity
Treatment follows a stepwise approach, starting with the simplest interventions and escalating based on how you respond. The Tear Film and Ocular Surface Society (TFOS) DEWS II guidelines outline four stages.
For mild cases, the first step focuses on changes you can make at home. That includes using preservative-free artificial tears throughout the day, applying warm compresses to soften blocked oil glands, practicing lid hygiene (gently cleaning the eyelid margins), and making environmental adjustments like using a humidifier, taking screen breaks, and positioning yourself away from direct air vents. Dietary changes may also help. Omega-3 fatty acids from fish oil or flaxseed have anti-inflammatory properties that support tear quality.
When home care isn’t enough, prescription treatments come in at step two. Anti-inflammatory eye drops that calm the immune response on the ocular surface are a cornerstone. One widely used option works by blocking the inflammatory cascade and has been shown to both increase tear production and restore goblet cell density, improving the mucin layer over time. Topical steroids may be used for short-term flare control, while certain oral or topical antibiotics help with associated eyelid inflammation.
In-Office Procedures
For moderate to severe meibomian gland dysfunction, in-office thermal treatments can be effective. Thermal pulsation devices apply controlled heat directly to the inner eyelid to melt thickened oil blocking the glands, followed by gentle expression to clear the obstruction.
Intense pulsed light (IPL) therapy, originally developed for skin conditions, has gained traction for OSD. It works through several mechanisms: triggering anti-inflammatory processes, closing off abnormal blood vessels along the eyelid margin, reducing bacterial load, and controlling Demodex mite populations that contribute to lid inflammation. Radiofrequency (RF) treatment, sometimes combined with IPL, uses electromagnetic energy to generate sustained heat in the tissue surrounding the meibomian glands, raising the temperature to around 40 to 41 degrees Celsius. This liquefies thickened oil more effectively than brief pulses of heat can. In one study of combined RF, IPL, and gland expression, patients saw symptom scores drop by roughly 61% and clinical signs of gland blockage improve by 69%.
What Happens Without Treatment
Left unmanaged, chronic OSD does more than cause discomfort. Persistent inflammation and a compromised tear film weaken the cornea’s natural defenses against infection. A damaged ocular surface is more vulnerable to bacterial, fungal, and viral keratitis, all of which can cause corneal ulceration, scarring, and significant vision loss. Herpes simplex virus infection of the cornea remains a leading cause of one-sided infectious blindness worldwide. Fungal keratitis can penetrate deep into the corneal tissue, and if treatment is delayed, perforation of the cornea becomes possible, sometimes requiring a corneal transplant or, in the worst cases, resulting in loss of the eye.
Even without infection, chronic surface damage leads to progressive corneal irregularity. Over time, this creates persistent blurry vision that doesn’t correct well with glasses. The inflammatory cycle also causes cumulative loss of goblet cells, which further destabilizes the tear film and makes the condition harder to reverse the longer it goes untreated. Early and consistent management makes a meaningful difference in long-term outcomes.